Published in Verh Dtsch Ges Inn Med on June 12, 1978
The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell (1993) 4.30
cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol (1992) 2.91
Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med (1995) 2.24
beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol (1994) 1.97
Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression. J Biol Chem (1996) 1.43
[Therapy of diabetes in adults using Glibornurid. Results and clinical studies]. Dtsch Med Wochenschr (1973) 1.38
Group B streptococci in human pathology. Zentralbl Bakteriol Orig (1970) 1.31
Surgery for Graves' disease: total versus subtotal thyroidectomy-results of a prospective randomized trial. World J Surg (2000) 1.19
Identification of a gene family regulated by transforming growth factor-beta. DNA Cell Biol (1991) 1.18
Site-directed mutagenesis of glycosylation sites in the transforming growth factor-beta 1 (TGF beta 1) and TGF beta 2 (414) precursors and of cysteine residues within mature TGF beta 1: effects on secretion and bioactivity. Mol Endocrinol (1992) 1.08
Intranasal GnRH therapy of maldescended testes. Horm Metab Res (1975) 1.07
Isolation of a cDNA clone encoding S-adenosylmethionine decarboxylase. Expression of the gene in mitogen-activated lymphocytes. J Biol Chem (1986) 1.03
Cloning and expression of the gene for the melanoma-associated ME20 antigen. DNA Cell Biol (1994) 0.95
Epidemiology and immunogenetic background of islet cell antibody--positive nondiabetic schoolchildren. Ulm-Frankfurt population study. Diabetes (1991) 0.95
Molecular cloning of a novel bone-forming compound: osteoinductive factor. DNA Cell Biol (1990) 0.94
Coincidence of calcium pyrophosphate and monosodium urate crystals in the synovial fluid of patients with gout determined by the cytocentrifugation technique. Ann Rheum Dis (2010) 0.93
Comparative studies on intermediary metabolism and hormonal counterregulation following human insulin (recombinant DNA) and purified pork insulin in man. Diabetes Care (1987) 0.92
Neutral salt effects on the velocity and activation volume of the lactate dehydrogenase reaction: evidence for enzyme hydration changes during catalysis. Arch Biochem Biophys (1977) 0.91
Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects. Diabetologia (1971) 0.89
Structure and chromosomal location of the human CD6 gene: detection of five human CD6 isoforms. J Immunol (1997) 0.88
24-hour variation in atrial natriuretic peptide. Lancet (1990) 0.87
Studies on cortisol substitution therapy in patients with adrenal insufficiency. Exp Clin Endocrinol (1983) 0.87
Treatment of cryptorchidism with pernasal gonadotropin-releasing hormone therapy. Fertil Steril (1978) 0.87
Influence of dexamethasone on nocturnal melatonin production in healthy adult subjects. J Pineal Res (1988) 0.86
Akathisia and metoclopramide. Lancet (1982) 0.86
Microscopic examination of stained cytospin preparations is a reliable method for the detection of calcium pyrophosphate crystals in synovial fluid. Scand J Rheumatol (2011) 0.86
Identification of a novel Drosophila melanogaster heat-shock gene, lethal(2)denticleless [l(2)dtl], coding for an 83-kDa protein. Gene (1996) 0.85
Identification of residues in CD6 which are critical for ligand binding. Biochemistry (1997) 0.85
The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test. Exp Clin Endocrinol (1989) 0.85
[Palatinite in type II diabetics. Effect on blood-glucose, serum-insulin, C-peptide and free fatty acids]. Dtsch Med Wochenschr (1982) 0.84
[Compliance problems in therapy with levothyroxine]. Med Klin (Munich) (1990) 0.84
Correlation of platelet MAO activity with introversion: a study on a German rural population. Psychiatry Res (1982) 0.84
Influence of subchronic intake of melatonin at various times of the day on fatigue and hormonal levels: a placebo-controlled, double-blind trial. J Pineal Res (1989) 0.84
[On the regulation of nonesterified fatty acids with special reference to prostaglandins]. Dtsch Med Wochenschr (1966) 0.83
Hirudin-induced pseudothrombocytopenia in a patient with EDTA-dependent platelet aggregation: report of a new laboratory artefact. Int J Lab Hematol (2009) 0.83
Cleavage of a hydrophilic C-terminal domain increases growth-inhibitory activity of oncostatin M. Mol Cell Biol (1990) 0.82
Classical and late-onset forms of congenital adrenal hyperplasia caused by 21-OH deficiency reveal different alterations in the C4/21-OH gene region. Mol Biol Med (1986) 0.82
Haemostasiological parameters as risk factor for new arterial occlusions in diabetics. Klin Wochenschr (1986) 0.81
Histometric investigations on the testicular tissue of rats with alloxan diabetes and Chinese hamsters with spontaneous diabetes. Acta Endocrinol (Copenh) (1967) 0.81
[Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics]. Arzneimittelforschung (1974) 0.81
The effect of pizotifen, a serotonin antagonist, and of pirenzepine, a muscarinic antagonist, on hormonal responses to metoclopramide in healthy subjects. Arzneimittelforschung (1984) 0.81
Synchronous pulmonary carcinoid tumour and non-Hodgkin's lymphoma: report of two cases. Thorax (1989) 0.80
Factors altering platelet monoamine oxidase. The influence of oral glucose intake. Metabolism (1979) 0.80
Effect of human atrial natriuretic peptide on blood glucose concentrations and hormone stimulation during insulin-induced hypoglycaemia in healthy man. Eur J Clin Pharmacol (1989) 0.80
[Secondary failures in modern therapy of diabetes mellitus with blood glucose lowering sulfonamides (author's transl)]. Med Klin (1977) 0.80
The inhibiting effect of trilostane on adrenal steroid synthesis: hormonal and morphological alterations induced by subchronic trilostane treatment in normal rats. Res Exp Med (Berl) (1982) 0.80
Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome. Hum Genet (1997) 0.80
In vitro activity of biosynthetic human diarginylinsulin. Diabetologia (1990) 0.80
The influence of acute and subchronic administration of various antidepressants on early morning melatonin plasma levels in healthy subjects: increases following fluvoxamine. J Neural Transm (1987) 0.80
Cloning and expression of an endothelin receptor subtype B from human prostate that mediates contraction. Mol Pharmacol (1995) 0.80
[Does bariatric surgery affect addiction to overeating and eating disorders?]. Chirurg (2012) 0.79
Immunogenetic markers in patients with Graves' disease. Klin Wochenschr (1991) 0.79
Cyproterone acetate in the treatment of infantile adrenogenital syndrome with precocious puberty. Acta Endocrinol Suppl (Copenh) (1973) 0.79
Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide. II. Repeated administration in combination with glucose. Diabetologia (1971) 0.79
Molecular, biological, and preliminary structural analysis of recombinant bryodin 1, a ribosome-inactivating protein from the plant Bryonia dioica. Biochemistry (1997) 0.79
[Toxic shock syndrome. Description of 2 cases from the Frankfurt district]. MMW Munch Med Wochenschr (1983) 0.79
[Pharmacodynamics and pharmacokinetics of 2 glibenclamide preparations in type 2 diabetes. Intraindividual double-blind comparison of Euglucon 5 (HB 419) and Euglucon N (HB 420)]. Dtsch Med Wochenschr (1984) 0.79
Studies about unconjugated androstenediol in human peripheral plasma. J Clin Endocrinol Metab (1973) 0.79
Cloning and characterization of murine CD6. Mol Immunol (1995) 0.79
[Botulism of aquatic birds at the Starý u Pohorelic pond (Breclav District)]. Vet Med (Praha) (1984) 0.79
Melatonin and cortisol increase after fluvoxamine. Br J Clin Pharmacol (1986) 0.78
Human fetal pancreas transplants in nu/nu mice. Lancet (1977) 0.78
Transplantation of human fetal pancreas: experience in thymusaplastic mice and rats and in a diabetic patient. Diabetes (1980) 0.78
[A new test-strip for checking blood-sugar levels]. Dtsch Med Wochenschr (1982) 0.78
[Etiology and prognosis of diabetic coma--a retrospective study]. Verh Dtsch Ges Inn Med (1971) 0.77
Successful treatment of primary adrenal insufficiency due to malignant non-Hodgkin's lymphoma. Clin Investig (1992) 0.77
Aspartic acid at position 57 of the HLA-DQ beta chain is protective against future development of insulin-dependent (type 1) diabetes mellitus. Klin Wochenschr (1991) 0.77
Outbreak of enterocolitis caused by an enteroinvasive E. coli (serotype O 164, synonym serotype 147). Zentralbl Bakteriol Mikrobiol Hyg A (1982) 0.77
Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study. Int Angiol (1987) 0.77
[The effect of atrial natriuretic peptide on glucose tolerance and insulin level]. Med Klin (Munich) (1990) 0.77
[Determination of TSH receptor antibodies--clinical value]. Klin Wochenschr (1986) 0.77
Human atrial natriuretic peptide (hANP) has no effect upon dopaminergic pathways: preliminary evidence in nude mice bearing heterotransplanted human CONN's adenoma tissue. Klin Wochenschr (1986) 0.77
Infant botulism type B in central Europe. Zentralbl Bakteriol Mikrobiol Hyg A (1981) 0.77
Mutation analysis and therapeutic response to granulocyte colony-stimulating factor in a case of hyperimmunoglobulin M syndrome with chronic neutropenia. J Pediatr Hematol Oncol (2000) 0.76
Re-evaluation of eye muscle autoantibody determination in Graves' ophthalmopathy: failure to detect a specific antigen by use of enzyme-linked immunosorbent assay, indirect immunofluorescence, and immunoblotting techniques. Acta Endocrinol (Copenh) (1989) 0.76
Circadian patterns of salivary melatonin and urinary 6-sulfatoxymelatonin before and after a 9 hour time-shift. Adv Exp Med Biol (1991) 0.76
The HLA-DQ beta non-Asp-57 allele: a predictor of future insulin-dependent diabetes mellitus in patients with autoimmune Addison's disease. Tissue Antigens (1991) 0.76
Thyrotoxic effect of high iodine doses on xenotransplanted autoimmune thyroid tissue in athymic nude mice. Acta Endocrinol Suppl (Copenh) (1987) 0.76
The role of adrenal medulla in endogenous dopaminergic inhibition of aldosterone secretion. Res Exp Med (Berl) (1986) 0.76
Pituitary-adrenocortical function in treated Hodgkin disease. Lancet (1990) 0.75
Testosterone metabolism in the isolated perfused human foetal liver. Horm Metab Res (1969) 0.75
Thyroid hormone binding inhibition in critically ill patients--who is the inhibitor? Exp Clin Endocrinol (1990) 0.75
[Free fatty acids in the serum in critical diseases: do they play a role in the protein binding of thyroid hormones?]. Klin Wochenschr (1988) 0.75
Non-esterified fatty acids, serum insulin and blood glucose after a beta-receptor blocking agent in normal, hypophysectomized, diabetic and hypophysectomized-diabetic dogs. Acta Endocrinol Suppl (Copenh) (1973) 0.75
Morphologic testicular changes in rats after biopsy or puncture. Acta Endocrinol Suppl (Copenh) (1973) 0.75
[FSH and ICSH plasma level in diabetics with potency disorders]. Verh Dtsch Ges Inn Med (1971) 0.75
Testicular function and morphology in rabbits following active immunization with testosterone or estradiol. Acta Endocrinol Suppl (Copenh) (1973) 0.75
[Andrologic studies, testosterone plasma level and chorionic gonadotropin loading in diabetics with potency disorders]. Verh Dtsch Ges Inn Med (1971) 0.75
Thyroid function and morphology in rabbits following active immunization with thyroxine or triidothyronine. Acta Endocrinol Suppl (Copenh) (1973) 0.75
Unconjugated 5-androstene-3beta, 17beta-diol in human plasma. Acta Endocrinol Suppl (Copenh) (1973) 0.75
[Experimental and clinical findings during the use of synthetic thyrotropin releasing hormone in man]. Verh Dtsch Ges Inn Med (1971) 0.75
Clinical experience with glibenclamide in 300 diabetics. Postgrad Med J (1970) 0.75